Endace OS 40 mg Oral Suspension 120 ml belongs to a class of medications called ‘Progestogens’ used as a symptomatic treatment in patients with breast cancer and endometrial cancer. Breast cancer develops in cells of the breast cells characterized by a lump in the breast, a change in the shape of the nipple or breast, and bloody discharge from the nipples. Endometrial cancer is the cancer of the womb's lining (uterus), characterized by pelvic pain, bleeding between periods, and pain during sex.
Endace OS 40 mg Oral Suspension 120 ml contains ‘Megestrol’, which belongs to the class of ‘Progestogens’. It works similarly to the female hormone ‘progesterone’. It interferes with the production or action of hormones involved in cancer growth. This effect helps to slow down the progression of cancer and reduce the symptoms associated with cancer.
Endace OS 40 mg Oral Suspension 120 ml is available in the form of a tablet and oral suspension. You should take this medicine exactly as prescribed by your doctor. The common side-effects of Endace OS 40 mg Oral Suspension 120 ml are an increase in appetite, weight gain, shortness of breath, hot flushes (reddening of the face and neck), high blood pressure, increased blood sugar levels, rounded face, constipation, and swelling of a vein due to a blood clot. If any of these side effects persist or get worse, inform your doctor immediately.
Do not take Endace OS 40 mg Oral Suspension 120 ml if allergic to Megestrol or any contents. Before taking Endace OS 40 mg Oral Suspension 120 ml, inform your doctor if you have severe liver problems, a history of thrombophlebitis (blood clots), stroke, adrenal gland disorder, and diabetes. Endace OS 40 mg Oral Suspension 120 ml should be used with caution in elderly patients. Endace OS 40 mg Oral Suspension 120 ml is not recommended for children, pregnant women, and breastfeeding mothers. Do not consume alcohol, as it may increase the risk of side effects. Endace OS 40 mg Oral Suspension 120 ml may not affect your ability to drive.